{"id":"https://openalex.org/W4361959697","doi":"https://doi.org/10.1158/1078-0432.c.6529226","title":"Data from Anti-Folate Receptor Alpha\u2013Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer","display_name":"Data from Anti-Folate Receptor Alpha\u2013Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361959697","doi":"https://doi.org/10.1158/1078-0432.c.6529226"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6529226","doi":"https://doi.org/10.1158/1078-0432.c.6529226","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6529226","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6529226","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Anthony Cheung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Cheung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068012310","display_name":"James W. Opzoomer","orcid":"https://orcid.org/0000-0001-6842-756X","observed_orcids":["https://orcid.org/0000-0001-6842-756X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Opzoomer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072271516","display_name":"Kristina M. Ilieva","orcid":"https://orcid.org/0000-0002-6877-3793","observed_orcids":["https://orcid.org/0000-0002-6877-3793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristina M. Ilieva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034034892","display_name":"Patrycja Gazi\u0144ska","orcid":"https://orcid.org/0000-0001-5031-1913","observed_orcids":["https://orcid.org/0000-0001-5031-1913"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrycja Gazinska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047287597","display_name":"Ricarda M. Hoffmann","orcid":"https://orcid.org/0000-0001-9489-1032","observed_orcids":["https://orcid.org/0000-0001-9489-1032"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ricarda M. Hoffmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015356443","display_name":"Hasan Mirza","orcid":"https://orcid.org/0000-0002-6460-5290","observed_orcids":["https://orcid.org/0000-0002-6460-5290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hasan Mirza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019992879","display_name":"Rebecca Marlow","orcid":"https://orcid.org/0000-0001-7525-7968","observed_orcids":["https://orcid.org/0000-0001-7525-7968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Marlow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048013324","display_name":"Erika Francesch-Domenech","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika Francesch-Domenech","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067553302","display_name":"Matthew W. Fittall","orcid":"https://orcid.org/0000-0002-5172-4100","observed_orcids":["https://orcid.org/0000-0002-5172-4100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Fittall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071844686","display_name":"Diana Dominguez-Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Dominguez Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Angela Clifford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Clifford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061095029","display_name":"Luned M. Badder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luned Badder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110323","display_name":"Nirmesh Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nirmesh Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023970121","display_name":"Silvia Mele","orcid":"https://orcid.org/0000-0003-3709-5739","observed_orcids":["https://orcid.org/0000-0003-3709-5739"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Mele","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010500551","display_name":"Giulia Pellizzari","orcid":"https://orcid.org/0000-0003-0387-1912","observed_orcids":["https://orcid.org/0000-0003-0387-1912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giulia Pellizzari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039081890","display_name":"Heather J. Bax","orcid":"https://orcid.org/0000-0003-0432-4160","observed_orcids":["https://orcid.org/0000-0003-0432-4160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather J. Bax","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015311837","display_name":"Silvia Crescioli","orcid":"https://orcid.org/0000-0002-1909-5957","observed_orcids":["https://orcid.org/0000-0002-1909-5957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Crescioli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110417981","display_name":"Gyula Petr\u00e1nyi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gyula Petranyi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023442852","display_name":"Daniel Larcombe-Young","orcid":"https://orcid.org/0000-0002-3579-8695","observed_orcids":["https://orcid.org/0000-0002-3579-8695"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Larcombe-Young","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041984199","display_name":"Debra Hannah Josephs","orcid":"https://orcid.org/0000-0002-5610-9123","observed_orcids":["https://orcid.org/0000-0002-5610-9123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debra H. Josephs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037526893","display_name":"Silvana Canevari","orcid":"https://orcid.org/0000-0002-2963-3587","observed_orcids":["https://orcid.org/0000-0002-2963-3587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvana Canevari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087949502","display_name":"Mariangela Figini","orcid":"https://orcid.org/0000-0001-9001-8754","observed_orcids":["https://orcid.org/0000-0001-9001-8754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariangela Figini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113139318","display_name":"Sarah E. Pinder","orcid":"https://orcid.org/0000-0003-4167-8910","observed_orcids":["https://orcid.org/0000-0003-4167-8910","https://orcid.org/0000-0002-1680-6530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Pinder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034983939","display_name":"Frank Oliver Nestle","orcid":"https://orcid.org/0000-0003-1033-5309","observed_orcids":["https://orcid.org/0000-0003-1033-5309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank O. Nestle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055450638","display_name":"Cheryl Gillett","orcid":"https://orcid.org/0000-0003-3643-4057","observed_orcids":["https://orcid.org/0000-0003-3643-4057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl Gillett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034748028","display_name":"James F. Spicer","orcid":"https://orcid.org/0000-0003-3732-8491","observed_orcids":["https://orcid.org/0000-0003-3732-8491","https://orcid.org/0009-0005-6890-2128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James F. Spicer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054103832","display_name":"Anita E. Grigoriadis","orcid":"https://orcid.org/0000-0003-3434-201X","observed_orcids":["https://orcid.org/0000-0003-3434-201X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anita Grigoriadis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087121536","display_name":"Andrew N.J. Tutt","orcid":"https://orcid.org/0000-0001-8715-2901","observed_orcids":["https://orcid.org/0000-0001-8715-2901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew N.J. Tutt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064339857","display_name":"Sophia N. Karagiannis","orcid":"https://orcid.org/0000-0002-4100-7810","observed_orcids":["https://orcid.org/0000-0002-4100-7810"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophia N. Karagiannis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.1509999930858612,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/folate-receptor-alpha","display_name":"folate receptor alpha","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8709999918937683},{"id":"https://openalex.org/keywords/folate-metabolism","display_name":"folate metabolism","score":0.7639999985694885},{"id":"https://openalex.org/keywords/thymidylate-synthase","display_name":"thymidylate synthase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/methylenetetrahydrofolate-reductase","display_name":"methylenetetrahydrofolate reductase","score":0.9980000257492065},{"id":"https://openalex.org/keywords/src-signaling","display_name":"Src signaling","score":0.9490000009536743},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9990000128746033},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8389999866485596},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6620000004768372},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4180000126361847}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.747200071811676},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5881962776184082},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.5513899922370911},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5351119637489319},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5338099598884583},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4220251441001892},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41268134117126465},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.32808905839920044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32695311307907104},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29074716567993164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2300243377685547}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6529226","doi":"https://doi.org/10.1158/1078-0432.c.6529226","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6529226","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6529226","doi":"https://doi.org/10.1158/1078-0432.c.6529226","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6529226","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7599999904632568}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2887583339","https://openalex.org/W3005471253","https://openalex.org/W2789622869","https://openalex.org/W3049066618","https://openalex.org/W3049518024","https://openalex.org/W2923111198","https://openalex.org/W2603010884","https://openalex.org/W2092334961","https://openalex.org/W2593303364","https://openalex.org/W2787284508"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Highly":[2],"aggressive":[3,108],"triple-negative":[4],"breast":[5,48,192],"cancers":[6,49],"(TNBCs)":[7],"lack":[8],"validated":[9],"therapeutic":[10,228],"targets":[11],"and":[12,55,61,67,82,94,112,141,155,158,191,197,201,212,222],"have":[13],"high":[14,120],"risk":[15,121],"of":[16,27,74,86,107,122,135,162],"metastatic":[17],"disease.":[18],"Folate":[19],"receptor":[20],"alpha":[21],"(FR\u03b1)":[22],"is":[23,102,125,207],"a":[24,119,171,224],"central":[25],"mediator":[26],"cell":[28,163,184,220,240],"growth":[29],"regulation":[30],"that":[31],"could":[32],"serve":[33],"as":[34,231],"an":[35,87],"important":[36],"target":[37,226],"for":[38,227],"cancer":[39,183,193,219],"therapy.":[40],"Experimental":[41],"Design:":[42],"We":[43,69],"evaluated":[44],"FR\u03b1":[45,75,90,101,152,206],"expression":[46,134],"in":[47,76,92,95,104,113,145,160,186,209,218],"by":[50,79,188],"genomic":[51],"(n":[52,57],"=":[53,58],"3,414)":[54],"IHC":[56],"323)":[59],"analyses":[60],"its":[62],"association":[63],"with":[64,118,127,170],"clinical":[65],"parameters":[66],"outcomes.":[68],"measured":[70],"the":[71,83],"functional":[72],"contributions":[73],"TNBC":[77,97,176,211],"biology":[78],"RNA":[80,148],"interference":[81,149],"antitumor":[84,238],"functions":[85],"antibody":[88,167],"recognizing":[89],"(MOv18-IgG1),":[91],"vitro,":[93],"human":[96,189],"xenograft":[98,177,203],"models.":[99],"Results:":[100],"overexpressed":[103,208],"significant":[105],"proportions":[106],"basal":[109],"like/TNBC":[110],"tumors,":[111],"postneoadjuvant":[114],"chemotherapy\u2013residual":[115],"disease":[116],"associated":[117,126],"relapse.":[123],"Expression":[124],"worse":[128],"overall":[129],"survival.":[130],"TNBCs":[131],"show":[132],"dysregulated":[133],"thymidylate":[136],"synthase,":[137],"folate":[138,146],"hydrolase":[139],"1,":[140],"methylenetetrahydrofolate":[142],"reductase,":[143],"involved":[144],"metabolism.":[147],"to":[150],"deplete":[151],"decreased":[153],"Src":[154,172],"ERK":[156],"signaling":[157,221],"resulted":[159],"reduction":[161],"growth.":[164,178,204],"An":[165],"anti-FR\u03b1":[166],"(MOv18-IgG1)":[168],"conjugated":[169],"inhibitor":[173],"significantly":[174,198],"restricted":[175,199],"Moreover,":[179],"MOv18-IgG1":[180],"triggered":[181],"immune-dependent":[182],"death":[185],"vitro":[187],"volunteer":[190],"patient":[194],"immune":[195,239],"cells,":[196],"orthotopic":[200],"patient-derived":[202],"Conclusions:":[205],"high-grade":[210],"postchemotherapy":[213],"residual":[214],"tumors.":[215],"It":[216],"participates":[217],"presents":[223],"promising":[225],"strategies":[229],"such":[230],"ADCs,":[232],"or":[233],"passive":[234],"immunotherapy":[235],"priming":[236],"Fc-mediated":[237],"responses.":[241],"Clin":[242],"Cancer":[243],"Res;":[244],"24(20);":[245],"5098\u2013111.":[246],"\u00a92018":[247],"AACR.":[248]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-05T00:00:00"}